A world-leading medical solutions company
We design and supply medical solutions to enhance performance in healthcare – from the hospital to the home.
Around the world, healthcare systems and professionals are under pressure to deliver better care, to more people, for better value. They need innovative solutions they can trust. That’s where we come in. We’re here to advance performance in healthcare. So we’re always on the lookout for new ways to improve. Our focus: providing effective solutions and offering better value for money.
Solutions to improve outcomes
We have one purpose – to advance performance in healthcare across the world. So that healthcare professionals have what they need to achieve the best clinical, patient and financial outcomes.
But different healthcare professionals have different needs. So we start by listening and making sure we understand them. Then we create solutions that are right for them and for their patients, and that are supported by evidence.
We contribute to advancing performance in other ways too. By sharing knowledge about our specialist clinical areas. And by helping to shape healthcare policies and protocols to raise standards of care worldwide.
We have a strong commitment to healthcare professionals. And we’re proving it every day.
A global company with a Swedish heritage
Customers use our solutions in almost 100 countries – and we own operations in more than 40 of them.
Although we’re a global company, our headquarters are still in Gothenburg – just a short distance from the town of Mölnlycke (pronounced 'Mon-licka'). The place where the company was founded in 1849 and the origin of the Mölnlycke name.
We design and supply medical solutions to enhance performance in healthcare – from the hospital to the home.
Around the world, healthcare systems and professionals are under pressure to deliver better care, to more people, for better value. They need innovative solutions they can trust. That’s where we come in. We’re here to advance performance in healthcare. So we’re always on the lookout for new ways to improve. Our focus: providing effective solutions and offering better value for money.
Solutions to improve outcomes
We have one purpose – to advance performance in healthcare across the world. So that healthcare professionals have what they need to achieve the best clinical, patient and financial outcomes.
But different healthcare professionals have different needs. So we start by listening and making sure we understand them. Then we create solutions that are right for them and for their patients, and that are supported by evidence.
We contribute to advancing performance in other ways too. By sharing knowledge about our specialist clinical areas. And by helping to shape healthcare policies and protocols to raise standards of care worldwide.
We have a strong commitment to healthcare professionals. And we’re proving it every day.
A global company with a Swedish heritage
Customers use our solutions in almost 100 countries – and we own operations in more than 40 of them.
Although we’re a global company, our headquarters are still in Gothenburg – just a short distance from the town of Mölnlycke (pronounced 'Mon-licka'). The place where the company was founded in 1849 and the origin of the Mölnlycke name.
Location: Sweden, Gothenburg
Employees: 5001-10000
Phone: +46 31 722 30 00
Founded date: 1998
Investors 1
Date | Name | Website |
- | BioVenture... | azbioventu... |
Mentions in press and media 33
Date | Title | Description |
14.11.2024 | Gothenburg increasingly dominant within Swedish R&D | Gothenburg increasingly dominant within Swedish R&D Thu, Nov 14, 2024 08:55 CET Report this content Gothenburg is solidifying its position as an innovation powerhouse, with business R&D expenditure growing significantly. In 2023, co... |
09.11.2024 | The Future of Healthcare: Mergers, Innovations, and Antimicrobial Advances | In the ever-evolving landscape of healthcare, two recent developments shine a spotlight on the industry's future. General Catalyst's acquisition of Summa Health and Ondine Biomedical's funding raise are not just transactions; they are pivot... |
08.11.2024 | Ondine Biomedical: Life Sciences Company Raises C$16 Million | Canadian life sciences company Ondine Biomedical announced it is accelerating its final preparations for a fourth quarter start to its key pivotal US Phase 3 trial following its recent successful raise of C$16 million. Along with strong sup... |
30.10.2024 | Stay Raises $3M in Seed Funding | Stay, a São Paulo, Brazil-based corporate pension startup, raised $3M in seed funding. The round was led by Better Tomorrow Ventures and MAYA Capital with participaiton from 17Sigma, Grão, and Ralicap, alongside angel investors Aaron Schumm... |
24.10.2024 | Mölnlycke® Health Care and Transdiagen announce research collaboration to drive innovation in wound care | Mölnlycke® Health Care and Transdiagen announce research collaboration to drive innovation in wound care Thu, Oct 24, 2024 16:08 CET Report this content Gothenburg 24 October 2024: Today, Mölnlycke Health Care, a world leading MedTech compa... |
17.10.2024 | Interim Management Statement January-September 2024 | Interim Management Statement January-September 2024 Thu, Oct 17, 2024 08:15 CET Report this content "Amid all the unpredictability, one thing remains perfectly clear: competition is fierce, requiring our companies, and ourselves, to co... |
01.10.2024 | Mölnlycke[®] Health Care acquires P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn[®], a range of solutions for wound cleansing and moisturising | Mölnlycke[®] Health Care acquires P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn[®], a range of solutions for wound cleansing and moisturising Tue, Oct 01, 2024 14:21 CET Report this content Today, Mölnlycke Health Care, a w... |
23.09.2024 | Mölnlycke and Ondine join forces against HAIs | Mölnlycke and Ondine join forces against HAIs Mon, Sep 23, 2024 09:22 CET Report this content Mölnlycke Health Care partners with Ondine for Steriwave distribution collaboration in the key markets of the UK, Europe and the Middle East. Goth... |
17.09.2024 | Inger Rydin is appointed interim COO and takes office immediately | Inger Rydin is appointed interim COO and takes office immediately Tue, Sep 17, 2024 17:55 CET Report this content Integrum AB (publ), the medical technology company that improves the lives of amputees, announces that Inger Rydin has been ap... |
03.09.2024 | SKF announces changes to Group Management | GOTHENBURG, Sweden, Sept. 3, 2024 /PRNewswire/ -- SKF announces the appointment of Susanne Larsson as Senior Vice President and Chief Financial Officer of SKF Group. Susanne will join SKF, at the latest, in the beginning of March 2025. This... |
Show more